Ischaemia-modified albumin in dilated cardiomyopathy

Annals of Clinical Biochemistry

Volumn 46, Issue 3, 2009, Pages 241-243

  Sbarouni, Eftihia ^a   Georgiadou, Panagiota ^a   Koutelou, Maria ^a   Sklavainas, Ioannis ^a   Panagiotakos, Demosthenes ^a   Voudris, Vassilis ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISCHAEMIA MODIFIED ALBUMIN; LOOP DIURETIC AGENT; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ADULT; AGED; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SERUM ALBUMIN; YOUNG ADULT;

EID: 66249117968     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009022     Document Type: Article

References (18)

1. Horwich TB, Patel J, MacLellan R, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833-838 (Pubitemid 37022125)
2. Hudson MP, O'Connor CM, Gattis WA, et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004;147:546-552 (Pubitemid 38880881)
3. Peacock WF, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-2126
4. Suguira T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y. Circulating levels of myocardial proteins predict future deterioration of congestive heart failure. J Card Fail 2005;11:504-509 (Pubitemid 41399889)
5. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159
6. Bar-Or D, Winkler JV, VanBenthysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-991 (Pubitemid 32479211)
7. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-2405 (Pubitemid 36605219)
8. Quiles J, Roy D, Gaze D, et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003;92:322-324 (Pubitemid 36897723)
9. Garrido IP, Roy D, Calvino R, et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol 2004;93:88-90 (Pubitemid 38022041)
10. Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an albumin binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-470 (Pubitemid 32222460)
11. Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-585 (Pubitemid 36379523)
12. Sinha M, Roy D, Gaze D, Collinson P, Kaski JC. Role of 'ischemia-modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34
13. Peacock F, Morris LD, Anwaruddin S, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152:253-262 (Pubitemid 44093396)
14. Cichota LC, Moresco RN, Duarte MM, da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal 2008;22:1-5
15. Govender R, De Greef J, Delport R, Becker PJ, Vermaak WJ. Biological variation of ischemia-modified albumin in healthy subjects. Cardiovasc J Afr 2008;19:141-144
16. Sato Y, Kita T, Takatsu T, Kimura T. Biochemical markers of myocyte injury in heart failure. Heart 2004;90:1110-1113 (Pubitemid 39279891)
17. Fonarow GC, Horwich TB. Combining Natriuretic Peptides and necrosis markers in determining prognosis in heart failure. Rav Cardiovasc Med 2003;4(Suppl 4):S20-8
18. Morrow DA, De Lemos JA, Sabatine MS, Antman EM. The search for a biomarker of cardiac ischemia. Clin Chem 2003;49:537-539 (Pubitemid 36379516)